May 5, 2021

TRIO Continues Support for ACRP Partners in Workforce Advancement

May 5, 2021 – The Association of Clinical Research Professionals (ACRP) is pleased to announce the continued support of TRIO (Translational Research in Oncology) as a Workforce Champion member of the Partners in Workforce Advancement.

Partners in Workforce Advancement is a multi-stakeholder collaborative initiative to grow and expand the diversity of the clinical research workforce, and to set and support standards for workforce competence.

“Organizations aligned with ACRP’s mission are working together to improve clinical trial quality and outcomes for patients by focusing where others have not – workforce planning, development, and assessment. Why? Because in clinical research, people are everything,” says Jim Kremidas, ACRP Executive Director. “We are thankful for the continued support of TRIO and look forward to working together to overcome these critical challenges.”

Partners in Workforce Advancement members—who now include more than 25 sponsors, CROs, investigator sites, academic institutions, regulatory agencies, and more—provide strategic direction and support for initiatives to:

• Grow and Diversify the Workforce
• Define, Align and Validate Competency Standards for Research Roles
• Support Sites During COVID-19 Pandemic and Beyond

“TRIO’s membership in the Partners in Workforce Advancement program has been a rewarding experience and continuing our relationship with ACRP was an easy decision,” says Launa Aspeslet, Chief Executive Officer of TRIO. “The commitment to best practices, growing the industry, and attracting diverse and inclusive clinical research professionals benefits both TRIO and the clinical trial community as a whole.”

How to Get Involved

ACRP’s Partners in Workforce Advancement drive strategic direction of the clinical research workforce, receive solutions to workforce challenges, and gain premium industry recognition.

***

About TRIO

TRIO advances translational cancer research by introducing innovative and novel targeted therapeutic concepts into the clinical trial setting. With international offices in Edmonton (Canada), Paris (France), Montevideo (Uruguay), TRIO’s global reach is expansive. Our goal as a not-for-profit clinical research organization is to find the shortest path to saving lives. Additional information on TRIO can be found by visiting https://trioncology.org/. Interested parties may also follow TRIO on Twitter (twitter.com/TRIOncology).